- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Self-monitoring of BP failed to diagnose preeclampsia early in high-risk pregnancies: JAMA
Blood pressure self-monitoring with telemonitoring, as compared to standard treatment, did not result in significantly earlier clinic-based identification of hypertension in pregnant women at higher risk of preeclampsia, says an article published in the Journal of American Medical Association.
Inadequate treatment of high blood pressure (BP) is a major contributor to maternal mortality. Self-monitoring of blood pressure has been demonstrated to enhance hypertension diagnosis and therapy in the general population; however, little is known regarding its utility during pregnancy. As a result, Katherine L. Tucker and colleagues undertook this study to see if self-monitoring of blood pressure in high-risk pregnancies leads to early diagnosis of pregnant hypertension.
Randomized, unblinded clinical research including 2441 pregnant women at increased risk of preeclampsia who were recruited at a mean of 20 weeks' gestation from 15 hospital maternity units between November 2018 and October 2019. The last follow-up was finished in April 2020. Individuals in the study were randomly assigned to receive BP self-monitoring with telemonitoring (n = 1223) with normal care or usual prenatal care alone (n = 1218) without access to telemonitored BP. The primary outcome was the time it took for a health care practitioner to detect hypertension for the first time.
The key findings of this study were a follow:
1. The experiment was completed by 2346 (96%) of the 2441 randomized individuals.
2. The period from randomization to clinic hypertension recording was not substantially different between persons in the self-monitoring group and those in the usual care group.
3. During the experiment, eighteen significant adverse events were recorded, but none were deemed to be connected to the intervention (12 [1% ] in the self-monitoring group vs 6 [0.5% ] in the usual care group).
In conclusion, blood pressure self-monitoring with telemonitoring compared to usual care did not result in increased earlier clinic-based detection of hypertension in pregnant women at higher risk of preeclampsia.
Reference:
Tucker, K. L., Mort, S., Yu, L.-M., Campbell, H., Rivero-Arias, O., Wilson, H. M., Allen, J., Band, R., Chisholm, A., Crawford, C., Dougall, G., Engonidou, L., Franssen, M., Green, M., (2022). Effect of Self-monitoring of Blood Pressure on Diagnosis of Hypertension During Higher-Risk Pregnancy. In JAMA (Vol. 327, Issue 17, p. 1656). American Medical Association (AMA). https://doi.org/10.1001/jama.2022.4712
Medical Dialogues consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers. Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in.
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751